DDIEM: drug database for inborn errors of metabolism.

ABSTRACT:

Background

Inborn errors of metabolism (IEM) represent a subclass of rare inherited diseases caused by a wide range of defects in metabolic enzymes or their regulation. Of over a thousand characterized IEMs, only about half are understood at the molecular level, and overall the development of treatment and management strategies has proved challenging. An overview of the changing landscape of therapeutic approaches is helpful in assessing strategic patterns in the approach to therapy, but the information is scattered throughout the literature and public data resources.

Results

We gathered data on therapeutic strategies for 300 diseases into the Drug Database for Inborn Errors of Metabolism (DDIEM). Therapeutic approaches, including both successful and ineffective treatments,

SUBMITTER: Abdelhakim M 

PROVIDER: S-EPMC7291537 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature